← Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo

Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease

Jocelyn X. Jiang et al · Frontiers Media S.A · 2026

Acceso abierto disponible
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Acceso abierto disponible

Recurso identificado como acceso abierto, sin confirmar automáticamente si es texto completo directo.
Abrir recurso

Resumen

Descripción general del contenido del recurso.

IntroductionThe immune system is recognized as participating in the pathophysiology of psychiatric disease and there is renewed interest in identifying biomarkers of this immune activation. MethodsWe measured serum and cerebral spinal fluid (CSF) autoantibodies with other routine and novel markers of neuroinflammation, including CSF cytokines in patients with atypical psychiatric presentations of both psychotic and mood disorders (n=35). Their markers were compared with cohorts of non-inflammatory neurological disease (NIND) controls (n=18), patients with central nervous system (CNS) viral infection (n=22) and autoimmune encephalitis (AE; n=40). ResultsThe most common autoantibody detected in the serum of patients with psychiatric disease were anti-nuclear antibodies followed by thyroid autoantibodies. Few atypical psychiatric patients had abnormal conventional CSF markers of neuroinflammation (pleocytosis, oligoclonal bands, abnormal CSF IgG: albumin ratio). Further analysis of CSF revealed elevation of ITAC/CXCL11 in the psychiatric cohort. TARC/CCL17 was lower in the psychiatric cohort compared to other groups in a random-effects multinomial model, despite no significant differences on univariate analysis. When the values of CSF cytokines were examined in individual patients, six patients (17%) had at least one CSF cytokine greater than four standard deviations above the mean of the NIND cohort group. Extensive serological evaluation revised the diagnoses of six (17%) of our psychiatric group, and these patients’ showed improvement with immunosuppression. ConclusionOur results suggest a subset of people with atypical psychiatric disease may have a predominant immune contribution. This highlights the need for reevaluation and further consideration of differential diagnosis where patient presentations are not clinically typical, do not respond to conventional psychotropic treatment, or if other risk factors for autoimmunity are present.

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

al, J. X. J. E. (2026). Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease. https://doi.org/10.3389/fpsyt.2026.1665447

MLA

al, Jocelyn X. Jiang et. "Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease." 2026. https://doi.org/10.3389/fpsyt.2026.1665447.

Chicago

al, Jocelyn X. Jiang et. 2026. "Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease.". https://doi.org/10.3389/fpsyt.2026.1665447.

Harvard

al, J. X. J. E. 2026, Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease, Frontiers Media S.A, available at: https://doi.org/10.3389/fpsyt.2026.1665447 [Accessed 29 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
Markers of neuroinflammation in the CSF of patients with difficult to treat psychiatric disease
Autor / colaboradores
Jocelyn X. Jiang et al
Editorial
Frontiers Media S.A
Año de publicación
2026
ISSN
1664-0640
ISSN
1664-0640
Idioma
eng

Materias

Explorá otros recursos relacionados a partir de estas materias.

Copiado